Posts

From recreational to novel psychotherapeutic drugs

/in , , , , , /by

The utility of classical drugs used to treat psychiatric disorders (e.g., antidepressants, anxiolytics) is often limited by issues of lack of efficacy, delayed onset of action or side effects. Psychoactive substances have a long history of being used as tools to alter consciousness and as a gateway to approach the unknown and the divinities. These substances were initially obtained from plants and animals and more recently by chemical synthesis, and its consumption evolved toward a more recreational use, leading to drug abuse-related disorders, trafficking, and subsequent banning by the authorities. Read more

Drug market trends of cocaine, ATS and NPS: 2022

/in , , /by

Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS. Read more

An Update on the Implications of New Psychoactive Substances in Public Health

/in , , , , , /by

The emergence of new psychoactive substances has earned a great deal of attention, and several reports of acute poisoning and deaths have been issued involving, for instance, synthetic opiates. Read more

New psychoactive substances and low-income countries: a burgeoning crisis

/in /by

New psychoactive substances (NPS) are compounds intended to replicate the effects of legal and illegal drugs. The continuous detection of new NPS via several forensic toxicology techniques attests to the considerable NPS popularity all over the world, although such determinations rely on still indecisive findings, given the elusiveness inherent in NPS and the the lack of standardized and uniformly applied detection and screening techniques. A worrisome and neglected issue is the proliferation of NPS and other drugs of abuse in developing countries. Read more

Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports

/in /by

In recent years, an increase in the frequency of hospitalizations of patients taking newer and newer psychoactive substances has been observed around the world. Each year, authors publish case reports of patients who consumed previously unknown NPS. Most publications of this type concern the period between 2014 and 2016. However, no publication systematically reviews the pharmacotherapy used in these cases. This study aims to review the case reports of patients taking NPS published between 2010 and 2019, as well as analyzing the pharmacotherapy used. Read more

Molecular Mechanisms of Action of Novel Psychoactive Substances

/in /by

Novel psychoactive substances (NPS) represent a severe health risk for drug users. Even though the phenomenon has been growing since the early 2000s, the mechanisms of action of NPS at the receptors and beyond them are still scarcely understood. The aim of the present study was to provide a systematic review of the updated knowledge regarding the molecular mechanisms underlying the toxicity of synthetic opioids, cannabinoids, cathinones, and stimulants. Read more

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature

/in /by

Background and Objectives:  Over the past twenty years a large number of new psychoactive substances (NPS) have entered and modified the recreational drug scene. Their intake has been associated with health-related risks, especially so for vulnerable populations such as people with severe mental illness, who might be at higher risk of suicidality or self-injurious behavior. This paper aims at providing an overview of NPS abuse and the effects on mental health and suicidality issues, by performing a literature review of the current related knowledge, thereby identifying those substances that, more than others, are linked to suicidal behaviors. Read more

New psychoactive substances: a review and updates

/in /by

You can read this open access article at THIS LINK. Read more

People Who Use NPS/Stimulants: Basic Needs and Barriers in Access to HIV Related Medical and Social Services in Moldova

/in /by

Despite grand achievements on national, regional and international levels in response to the HIV epidemic, it remains a major public health issue. The representatives of Key Populations (KP) and their sexual partners have been disproportionately affected by the rise in HIV infections, which is further exacerbated by inadequate availability of integrated HIV prevention services. Read more

People Who Use NPS/Stimulants: Basic Needs and Barriers in Access to HIV Related Medical and Social Services in Ukraine

/in , /by

Today, while much has been achieved in the fight against the HIV epidemic, it remains a major global public health problem. The growing number of HIV infections that disproportionately affect representatives of Key Populations (KP) and their sexual partners is aggravated by inadequate availability of integrated HIV prevention services. Read more